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Abstract
Renal vasodilation and sympathoinhibition are recognized responses induced by hypernatremia, but the central neural
pathways underlying such responses are not yet entirely understood. Several findings suggest that A2 noradrenergic
neurons, which are found in the nucleus of the solitary tract (NTS), play a role in the pathways that contribute to body fluid
homeostasis and cardiovascular regulation. The purpose of this study was to determine the effects of selective lesions of A2
neurons on the renal vasodilation and sympathoinhibition induced by hypertonic saline (HS) infusion. Male Wistar rats (280–
350 g) received an injection into the NTS of anti-dopamine-beta-hydroxylase-saporin (A2 lesion; 6.3 ng in 60 nl; n = 6) or
free saporin (sham; 1.3 ng in 60 nl; n = 7). Two weeks later, the rats were anesthetized (urethane 1.2 g?kg21 b.wt., i.v.) and
the blood pressure, renal blood flow (RBF), renal vascular conductance (RVC) and renal sympathetic nerve activity (RSNA)
were recorded. In sham rats, the HS infusion (3 M NaCl, 1.8 ml?kg21 b.wt., i.v.) induced transient hypertension (peak at
10 min after HS; 962.7 mmHg) and increases in the RBF and RVC (14167.9% and 14067.9% of baseline at 60 min after HS,
respectively). HS infusion also decreased the RSNA (24565.0% at 10 min after HS) throughout the experimental period. In
the A2-lesioned rats, the HS infusion induced transient hypertension (661.4 mmHg at 10 min after HS), as well as increased
RBF and RVC (13365.2% and 13466.9% of baseline at 60 min after HS, respectively). However, in these rats, the HS failed to
reduce the RSNA (11563.1% at 10 min after HS). The extent of the catecholaminergic lesions was confirmed by
immunocytochemistry. These results suggest that A2 noradrenergic neurons are components of the neural pathways
regulating the composition of the extracellular fluid compartment and are selectively involved in hypernatremia-induced
sympathoinhibition.
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Introduction
Several lines of evidence have found that acute or chronic
hypernatremia engages several effector natriuretic mechanisms
that remain active until the reestablishment of the plasma sodium
concentration. [1–8]. Accordingly, previous studies have demon-
strated that the intravenous infusion of hypertonic saline (HS)
increases arterial blood pressure and renal vascular conductance
and induces regionally distinct changes in the sympathetic nerve
activity, such as increases in lumbar and decreases in renal and
splanchnic nerve discharge [2–4,8,9]. It is generally accepted that
the inhibition of renal sympathetic nerve activity (RSNA) is a key
component of these adjustments as it can produce renal
vasodilation, decrease renin secretion and reduce renal sodium
reabsorption, all mechanisms that, either in isolation or synergis-
tically, will lead to massive sodium loss. However, the central
aspects of the neural pathways involved in the activation of these
systems remain unclear.
Recent studies have demonstrated that A2 noradrenergic
neurons located within intermediate and caudal levels of the
nucleus of the solitary tract (NTS) are involved in body fluid
homeostasis and cardiovascular regulation [10–14]. Changes in
the volume and composition of the extracellular compartment
stimulate the expression of c-Fos and FosB in A2 neurons,
indicating their activation [12,15]. In addition, Duale et al. [10]
demonstrated that the silencing of A2 neurons affected water
consumption and urine output.
Neuroanatomical studies have shown that A2 noradrenergic
neurons receive sensory afferent input from the cardiovascular and
gastrointestinal systems [16,17]. These noradrenergic neurons
project throughout the central nervous system, including areas
related to the cardiovascular system and to the regulation of the
hydroelectrolytic balance, such as the median preoptic nucleus
(MnPO), the subfornical organ (SFO), the paraventricular nucleus
(PVN), and the supraoptic nucleus (SON) [18–21]. Overall, this
evidence suggests an important role of A2 neurons in the
maintenance of the circulating volume.
Therefore, in the present study, we tested the hypothesis that
the renal sympathoinhibition and vasodilation, induced by acute
increases in the plasma sodium levels, depend upon the integrity of
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A2 neurons. We used anti-dopamine b-hydroxylase (DbH) saporin
to induce lesions in the noradrenergic neurons in the NTS and
measured the effects of these lesions on the blood pressure pressor,
renal vascular conductance, and sympathetic responses induced by
acute hypernatremia.
Results
Lesion of the A2 noradrenergic neurons with
nanoinjections of anti-DbH–saporin into the NTS
Tyrosine hydroxylase (TH)-positive neurons were found within
the ventrolateral medulla (VLM) and the NTS from positions
approximately 1800 mm caudal to 1900 mm rostral to the obex
(Figures 1 and 2). In the saporin-treated animals (sham; n= 7),
TH-positive neurons in the region between the obex and 1800 mm
caudal to the obex averaged approximately 20 cells per section (A2
neurons). In rats treated with bilateral nanoinjections of anti-DbH-
saporin into the NTS (n= 6), the number of TH-positive neurons
caudal to the obex was reduced to approximately six cells per
section. Overall in this region, which encompasses the area of the
A2 noradrenergic neurons, the number of TH-positive neurons
was reduced by 70% (range 66 to 88%) compared to the saporin-
treated animals (Figures 1 and 2).
The nanoinjection of anti-DbH-saporin into the NTS reduced
the number of TH-positive neurons in the C2 adrenergic cell
group. Within the region located from the obex up to 1900 mm
rostral (the region encompassing the C2 cells), a reduction of
approximately 34% in the number of TH immunopositive
neurons was observed (Figures 1 and 2). Slight reductions in the
total number of TH-positive neurons were also observed in the A1
and C1 cell groups in the VLM, although they did not reach
statistical significance. In the region from 1800 to 300 mm caudal
to the obex, A1 noradrenergic neurons were reduced by 16%
(p= 0.0591; Figures 1 and 2). Similarly, in the region from 300 mm
caudal to 1900 mm rostral to the obex, C1 adrenergic neurons
were reduced by 11% (p= 0.3296; Figures 1 and 2).
Effects of HS infusion on plasma sodium and blood
hemoglobin concentrations
The plasma sodium and hemoglobin concentration changes
that were induced by HS infusion were determined in sham and
A2-lesioned rats. The pre-infusion plasma sodium concentrations
were similar in sham (14161.2 mM; n= 4) and A2-lesioned rats
(14162.2 mM; n= 4). The plasma sodium levels increased
similarly after HS infusion in both groups (15061.4 mM and
14961.2 mM in sham and A2-lesioned rats, respectively, 10 min
after infusion) and remained at these levels throughout the
experimental period (14861.2 mM and 15061.7 mM 60 min
after HS infusion). Ten minutes after HS infusion, there were no
changes in the blood hemoglobin concentrations in sham
(2161.0%) and A2-lesioned rats (2160.9%). The blood hemo-
globin concentration remained at these levels throughout the
experimental period (2160.6% and 2160.8%, respectively,
60 min after HS infusion).
Effects of A2 noradrenergic neuron lesions on
cardiovascular and RSNA responses induced by HS
infusion
The body weight and baseline MAP, HR, RBF, RVC and
RSNA are shown in Table 1. These variables were similar in sham
rats and A2-lesioned rats.
In sham animals, the infusion of HS increased MAP by
962.7 mmHg 10 min after infusion (Figures 3A and 4A). MAP
returned to basal levels 20 min after the HS infusion
(661.8 mmHg of baseline values; Figures 3A and 4A). In sham
animals, a discrete reduction in the heart rate 10 min after the HS
infusion (213610.3 beatsNmin21 of baseline values; Figures 3A
and 4B) was observed. Ten minutes after the HS infusion, the RBF
and RVC increased to 14464.0 and 13566.3% of baseline values,
respectively, and they remained augmented after 60 min
(14167.9% and 14067.9% of baseline values, respectively;
Figures 3A, 4C–D). The reduction in the RSNA reached a nadir
approximately 10 min after the HS infusion (24565.0% of
baseline values; Figures 3A and 4E) and remained lower for the
remainder of the experimental period (241611.3% of baseline
values at 60 min after HS infusion; Figures 3A and 4E).
In A2-lesioned rats, the pressor response induced by the HS
infusion was similar to that of the sham group (661.4 mmHg
above baseline at 10 min after HS infusion; Figures 3B and 4A). A
sustained increase in the HR was also observed 10 min after the
HS infusion (1866.3 beats min21 of baseline values; Figures 3B
and 4B). The RBF and RVC increased after the HS infusion
(12862.5% and 12262.2% of baseline values 10 min after HS
infusion; Figures 3B and 4C–D) and remained augmented after
60 min (13365.2% and 13466.9% of baseline values; Figures 3B
and 4C–D). However, these increases were slightly lower than
those observed in the sham animals. In A2-lesioned rats, the
reduction in the RSNA was abolished and reversed to a slight
increase after the HS infusion (1563.1% of baseline levels 10 min
after HS infusion; Figures 3B and 4E); this difference reached
statistical significance beginning at 30 min after the HS infusion.
Figure 1. Medullary catecholaminergic neurons. Photomicro-
graphs taken at 3 levels of the medulla showing TH-immunoreactive
cells in the NTS (A2 noradrenergic neurons), CVLM (A1 noradrenergic
neurons) and RVLM (C1 adrenergic neurons) in rats nanoinjected with
unconjugated saporin (sham) or anti-DbH-saporin. Arrows indicate TH-
positive cells. Scale bar 50 mm.
doi:10.1371/journal.pone.0037587.g001
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Effects of A2 noradrenergic neuron lesions on
baroreceptor reflexes
The functionality of the baroreceptor reflexes was evaluated by
the analysis of the cardiac-related components of the RSNA and
the coherence between the AP and RSNA. In A2-lesioned rats,
RSNA bursts were synchronized with the cardiac cycle, as
demonstrated by PAP-triggered averaging of the RSNA
(Figure 5A). The RSNA power spectra displayed a peak that
corresponded to the HR, indicating a prominent role of the
baroreceptor reflexes in modulating spontaneous RSNA dis-
charge. In these animals, a correlation between the RSNA bursts
and the cardiac cycle led to high AP-RSNA coherence values
(mean 0.8360.04; Figure 5B). Similar results were observed in the
A2-lesioned rats, as shown by the synchronization of the RSNA to
the cardiac cycle (Figure 5A), a prominent peak in the power
spectra corresponding to the HR, and high AP-SNA coherence
(0.8560.04; Figure 5B).
Discussion
Previous studies have indicated that A2 neurons are involved in
the regulation of body fluid homeostasis [10–14,22–25]. However,
Figure 2. Lesion of A2 noradrenergic neurons with nanoinjections of anti-DbH-saporin into the NTS. Number and average (mean 6
S.E.M.) of TH-positive cells in 40-mm-thick sections from the dorsal (A) and the ventrolateral medulla (B). Sections were taken from 1.9 mm rostral to
the obex to 1.9 mm caudal to the obex in animals submitted to A2 or sham lesions. Bilateral nanoinjections of anti-DbH-saporin into the NTS
produced a loss of TH-containing neurons in this area (A2 group, loss = 70%; C2 group, loss = 34%), in the RVLM (C1 group, loss = 11%) and in the
CVLM (A1 group, loss = 16%). { p,0.05 compared with sham lesion.
doi:10.1371/journal.pone.0037587.g002
Table 1. Baseline values for body weight, MAP, HR, RBF, RVC and RSNA in sham and A2 lesioned rats.
Group
b.w.
g
MAP
mm Hg
HR
bpm
RBF
ml?min21
RVC
ml(min?mmHg)21
eRSNA
mV
Sham 31966 12364 346615 3.360.2 26.761.1 185614.6
A2 lesion 32365 12362 326615 3.160.5 25.064.1 183628.1
Values are means 6 S.E.M. b.wt., body weight; MAP, mean arterial pressure; HR, heart rate; RBF, renal blood flow; RVC, renal vascular conductance; #RSNA, integrate of
renal sympathetic nerve activity.
doi:10.1371/journal.pone.0037587.t001
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there was previously no evidence to support the contribution of
these neurons to the autonomic control of the circulating volume
composition. The present study provides a key new observation:
lesions of the A2 noradrenergic cluster reduced HS-induced renal
vasodilation. Moreover, in A2-lesioned rats, hypernatremia failed
to decrease renal sympathetic activity during the observation
period. Together, these results point out the involvement of A2
noradrenergic neurons in the autonomic responses that are
induced by acute changes in the plasma sodium concentration,
and the results specifically highlight their involvement in the
regulation of renal sympathetic nerve activity.
Several studies have aimed to quantitate and validate the
specificity of neuronal lesions induced by the central nanoinjection
of anti-DbH-saporin, and the results obtained are compelling.
Madden et al. [26] demonstrated that the nanoinjection of anti-
DbH-saporin into the C1 adrenergic neuron rostral cluster,
located in the rostroventrolateral medulla (RVLM) region,
promoted lesion of these neurons as well as lesions of A1 and
A5 catecholaminergic neurons. In addition to demonstrating that
the lesion effect is caused by the uptake of synaptic terminals, these
authors demonstrate that the anti-DbH-saporin could damage
noradrenergic and adrenergic neurons located in the nanoinjec-
tion site itself. It is postulated that, in these neurons, the
somatodendritic exocytosis of catecholamines resulted in the
exposure of DbH and therefore the possible uptake of the anti-
DbH-saporin complex via their soma and/or dendrites. In
agreement with these results, we have recently demonstrated that
the nanoinjection of anti-DbH-saporin into the caudoventrolateral
medulla (CVLM) region promoted specific lesions to the A1 cluster
located around the center of the nanoinjections [3,27]. As noted
earlier, the current study also shows that the nanoinjection of anti-
DbH-saporin in the NTS promoted, on average, a reduction of
approximately 70% in all of the catecholaminergic cells compared
to the control cluster (nanoinjection of saporin) of A2 noradren-
ergic neurons.
An important aspect to be considered is whether nanoinjections
of anti-DbH-saporin into the A2 area destroy the DbH-containing
cells outside of the NTS and if the results observed may be
attributed to these remote lesions. Our results indicate that
nanoinjections of anti-DbH-saporin into the NTS/A2 area
Figure 3. Typical examples. Digitized record of cardiovascular and sympathetic responses induced by hypertonic saline infusion in sham (A) and
A2-lesioned rats (B). ABP = arterial pressure, RBF = renal blood flow, RSNA = renal sympathetic nerve activity (RSNA), hexameth. = hexamethonium.
doi:10.1371/journal.pone.0037587.g003
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induced a discrete (16%) reduction in the total number of TH-
positive cells in the CVLM/A1 cluster and an 11% reduction in
the RVLM/C1 cluster. It is likely that these lesions result from the
uptake of the conjugated toxin by efferent projections from the
ventrolateral medulla to the A2 region of the NTS. Studies
performed in our laboratory have demonstrated that lesions of less
than 32% of the A1 noradrenergic cells produced by nanoinjec-
tions of anti-DbH-Saporin into the CVLM were ineffective in
altering the renal sympathoinhibition induced by sodium overload
(G.R.P. & S.L.C, unpublished observations). Consistent with these
results, Madden & Sved [28] demonstrated that sympathoexcita-
tory responses induced by baroreceptor unloading or chemore-
ceptor activation were abolished only in animals with lesions in
more than 80% of the C1 catecholaminergic group. These results
suggest that extensive lesions of cell groups are necessary to induce
significant and reproducible effects. Therefore, it is unlikely that
the lack of renal sympathoinhibition in the A2-lesioned rats in our
study may be due to the less than 20% lesions that were found in
the A1/C1 areas.
Previous studies have attempted to establish the effects of
hypernatremia on cardiovascular and renal parameters. Similar to
the results obtained in the present study, they describe sustained
increases of blood flow and renal vasculature conductance,
combined with transient hypertension and bradycardia
[2,3,8,9,27,29,30]. It is assumed that these adjustments are
triggered by an increase in the sodium plasma concentration,
part of an integrated set of responses to promote natriuresis and
thus restore the regular volume conditions. Moreover, we have
previously demonstrated that the vasodilation induced by sodium
overload is specific to the renal bed, as there is no change in the
aortic or mesenteric vascular conductance [9]. Evidence suggests
the renal vasodilation induced by sodium overload seems to
involve neural and humoral components, including a reduction of
the renal sympathetic nerve activity and the release of vasoactive
substances, such as ANP [2,3,5,8,31,32].
Studies have shown the importance of medullary noradrenergic
neurons in the integration of the mechanisms involved in the
autonomic, cardiovascular and respiratory systems [3,10–
Figure 4. Effects of A2 noradrenergic neuron lesions on cardiovascular and autonomic responses induced by hypernatremia. Effects
of infusion of hypertonic saline (3 M NaCl, 1.8 ml?Kg21 body weight) on mean arterial pressure (D MAP; A), heart rate (D HR; B), renal blood flow (D
RBF; C), renal vascular conductance (D RVC; D) and renal sympathetic nerve activity (D RSNA; E) in sham and A2-lesioned rats. The bars indicate the
moment of hypertonic saline infusion. Error bars indicate S.E.M. * p,0.05 compared with baseline; { p,0.05 compared with sham lesion.
doi:10.1371/journal.pone.0037587.g004
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15,22,24,25,27,33–36]. With regard to the A1 noradrenergic
cluster, several authors have shown that these neurons are
important for the response induced by changes in the circulating
volume [3,12,15,22,27,33–37]. Studies have demonstrated that
increases in the sodium plasma concentration induce the
expression of c-Fos in these noradrenergic neurons, indicating
their activation [15,23]. Recently, we have shown that specific
lesion of the A1 noradrenergic cluster abolishes the vasodilation
and the renal sympathoinhibition that are induced by hyperna-
tremia [3,27]. These results indicate that A1 neurons are involved
in both neural and humoral mechanisms in response to
hypernatremia, once their specific lesion abolishes the renal
sympathoinhibition and vasodilation that are induced by the
sodium overload.
With regard to the A2 cluster of noradrenergic neurons, recent
evidence has shown that the viral inactivation of these neurons
decreased the daily water intake [10], showing their involvement
in the behavioral regulation of the circulating volume. Other
studies on the expression of immediate early genes show that these
noradrenergic neurons located in the NTS are activated by
increases in the osmolality or plasma volume [12,23,24].
Extracellular neural activity recordings have identified NTS
neurons in which activity increases after sodium overload [24].
The present study shows that the specific lesion of A2 neurons
abolishes the renal sympathoinhibition induced by the infusion of
hypertonic saline. To the best of our knowledge, no other study
has yet demonstrated the participation of these neurons in the
autonomic component of the response to hypernatremia. In
addition, we have also demonstrated that the renal vasodilation
induced by sodium overload was not abolished but was reduced in
animals with A2 lesions, suggesting that the humoral component
of the response to hypernatremia is intact in these animals.
Therefore, while A1 noradrenergic neurons appear to modulate
both the endocrine and neural components that are observed in
response to hypernatremia, the A2 noradrenergic neurons seem to
be specifically related to the modulation of renal sympathetic
activity.
Anatomical studies have shown that medullary noradrenergic
neurons receive sensory information from baro- and cardiopul-
monary receptors [16,24,34,38,39]. From medullary catechol-
aminergic and non-catecholaminergic neurons, the information
about the circulating volume would be processed and transmitted
to hypothalamic centers involved in the regulation of osmolality.
In fact, both A1 and A2 catecholaminergic groups project densely
to hypothalamic targets as the PVN and MnPO [18,20,21,40–43].
The main difference is that, whereas A1 neurons project densely to
both magno- and parvocellular regions of the PVN, A2 neurons
project primarily to the dorsal and ventral parvocellular groups of
this nucleus [41]. These anatomical data are compatible with the
idea that A2 neurons may be selectively involved with the neural
regulation of sympathetic activity in response to acute hyperna-
tremia, whereas A1 neurons may be involved in the regulation of
both neuronal and humoral components.
The noradrenergic neurotransmission in the hypothalamic
regions appears to play a significant role in the responses induced
by changes in the circulating volume. Data have shown that the
nanoinjection of a-adrenergic-antagonists into the AV3V region
reduces the hypertension response and secretion of ANP and
oxytocin induced by sodium overload [44,45]. Similarly, recent
studies conducted by our laboratory have shown that the blockade
of a1 or a2 adrenoceptors located in the MnPO abolishes the renal
vasodilation induced by hypertonic saline infusion [4]. Thus, the
lesion of medullary noradrenergic neurons and the a adrenoceptor
blockade in the MnPO nucleus change the cardiovascular
outcome in response to hypernatremia, supporting the idea that
ascending projections from medullary noradrenergic neurons and
the MnPO nucleus mediate the endocrine and autonomic
adjustments involved in this response.
Together, the results obtained in this study are consistent with
the hypothesis that the A2 noradrenergic neurons activated by
peripheral afferents are part of the central pathways modulating
the adjustments induced by acute changes in osmolality. Thus, as
Figure 5. Effects of A2 noradrenergic neuron lesions on
baroreceptor reflexes. Post-systolic averages of arterial pressure
(AP) and renal sympathetic nerve activity (SNA) waves (A) and
coherence values between AP and SNA power spectrum (B) before
hypertonic saline infusion in sham and A2-lesioned rats.
doi:10.1371/journal.pone.0037587.g005
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these noradrenergic neurons are part of the pathways involved in
responses to changes in the plasma sodium concentration, a
dysfunction in these cells would result in the inefficient operation
of these adjustments, which could contribute to the development
of diseases such as arterial hypertension.
Materials and Methods
Animals
All experiments were conducted on adult male Wistar rats (280–
350 g). The animals came from the central animal house at the
Universidade Federal de Sa˜o Paulo. All protocols described here
were approved by the Medical Ethics Committee at the
Universidade Federal de Sa˜o Paulo (protocol # 0739/06) and
were performed in strict accordance with the Guidelines for Care
and Use of Laboratory Animals of the National Health Institute.
Nanoinjections of anti-DbH-saporin or saporin into the
NTS
The animals were anaesthetized with halothane (2–3% in
100% O2) and mounted prone on a stereotaxic apparatus (David
Kopf Instruments, Tujunga, CA, USA) with the incisor bar
11 mm below the interaural line. After partial removal of the
occipital bone, the meninges covering the dorsal surface of the
brainstem were cut and retracted, and the calamus scriptorius
was visualized. Nanoinjections of anti-DbH-saporin (6.3 ng in
60 nl; Advanced Targeting Systems, San Diego, CA, USA) or an
equimolar dose of saporin (1.3 ng in 60 nl; Advanced Targeting
Systems, San Diego, CA, USA) were made bilaterally at two
levels of the NTS. For all nanoinjections into the NTS, a glass
micropipette was positioned as follows: 20.5 and 20.0 mm
caudal to the calamusscriptorius, 0.0 mm lateral to the midline, and
0.3 mm ventral to the dorsal surface. These coordinates were
based on the region of the NTS comprising the A2 noradrenergic
group [46]. After nanoinjection, the micropipette was left in place
for 3–5 min. The incision was then closed, and the animals were
placed on a heated pad to maintain their body temperature
during recovery. Penicillin (60 000 IU kg21 b.wt., i.m.; Sigma-
Aldrich, St. Louis, MO, USA) was injected for prophylaxis after
the surgery. The animals were studied for 15–25 days after the
nanoinjections into the NTS.
Surgical procedures
On the day of experiments, the rats were anesthetized with
halothane (2–3% halothane in 100% O2), and the catheters were
inserted into the right femoral vein and artery. The right jugular
was also dissected, and a catheter was placed closer to the right
atrium for the HS infusion (see below). After the catheter
placement, the rats were removed from the halothane, and the
anesthesia was maintained with urethane (1.2 g?kg21 b.wt., i.v.;
Sigma-Aldrich, St. Louis, MO, USA). The trachea was
cannulated to reduce airway resistance, and the rats were
mounted prone on a stereotaxic apparatus (David Kopf
Instruments) with the bite bar set at 3.4 mm below the interaural
line. The postganglionic renal sympathetic nerve activity (RSNA)
was recorded from the left renal nerve with bipolar platinum
electrodes in a monopolar configuration. In experiments
measuring the renal blood flow (RBF), miniature ultrasonic
transit-time flow probes (Transonic Systems Inc., Ithaca, NY,
USA) were placed around the left renal artery. The body
temperature was kept at 3760.5uC with a thermostatically
controlled heated table.
Recording of arterial pressure, heart rate, and renal blood
flow
To register the blood pressure, the arterial catheter was
connected to a pressure transducer attached to a bridge amplifier.
The pulsatile pressure was recorded continuously with an MP150
analog-to-digital converter (Biopac Systems, Inc., Goleta, CA,
USA). The mean arterial pressure (MAP) and heart rate (HR) were
determined through the pulsatile signal with AcqKnowledge
software (version 3.7.1.; Biopac Systems, Inc., Goleta, CA,
USA). To measure the RBF, a flow probe was connected to an
ultrasonic transit-time flowmeter (Transonic Systems, Inc., Ithaca,
NY, USA).
Renal sympathetic nerve activity recording
The RSNA was recorded through the left renal nerve with
bipolar platinum electrodes. After exposure and isolation, the renal
nerve was placed on the recording electrodes and was covered
with warm mineral oil. The RSNA signals were obtained using a
high-impedance probe connected to an AC amplifier (ERS 100c;
Biopac Systems, Inc., Goleta, CA, USA). The signal was amplified
(20,000), passed through a band-pass filter (50–1,000 Hz) and
digitized at 3 kHz using an MP150 analog-to-digital converter.
The filtered nerve signal was rectified and integrated (1 s time
constant) using AcqKnowledge software. At the end of each
experiment, the background noise was determined as the average
value of the integrated voltage after a bolus injection of
hexamethonium (30 mg?kg21 b.wt., i.v.).
Acute increase in plasma sodium concentration
Hypertonic saline (3 M NaCl, 1.8 mlNkg21 b.wt., i.v.; Sigma-
Aldrich, St. Louis, MO, USA) was infused through the jugular
vein cannula for 1 min.
Blood sampling and analysis
Blood samples (200 ml each) were withdrawn from the femoral
vein cannula 5 min before and 10, 30 and 60 min after HS
infusion. After the sample was collected, an equal volume of sterile
0.15 M NaCl was injected to reduce changes in the extracellular
fluid volume brought about by sampling. The blood hemoglobin
concentration was measured immediately with a kit from Sigma
(Drabkin’s reagent, kit 525). The rest of the sample was
centrifuged for 5 min at 6000 g. The plasma was removed and
stored at220uC. The plasma sodium concentration was measured
with a flame photometer (model 943, Instrumentation Laboratory,
Lexington, MA).
Perfusion, fixation, and tissue collection
At the end of the experiments, the animals’ heart were perfused
with saline (0.15 M NaCl), followed by a solution of 4%
paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA) in
0.1 M sodium phosphate buffer (500 ml at pH 7.4). The brain
was removed and post fixed in a 4% paraformaldehyde solution
for 1–2 h and was then kept in 30% sucrose solution. The serial
coronal 40-mm brainstem sections were collected in four series and
were stored in 0.02 M potassium phosphate-buffered saline
(KPBS, Sigma; pH 7.4) at 4uC until immunohistochemical
staining.
Immunohistochemistry
Each fourth brainstem section was processed for immunohisto-
chemical detection of tyrosine hydroxylase (TH). The sections
were incubated for 15 min in 0.5% hydrogen peroxide in 0.02 M
KPBS (Sigma-Aldrich, St. Louis, MO, USA), followed by a 30-
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min incubation in 3.5% normal horse serum (Vector Laboratories
Inc., Burlingame, CA, USA) in 0.02 M KPBS. The sections were
incubated overnight at 4uC with mouse monoclonal antibody
(1:2000 dilution, Immuno Star Inc., Hudson, WI, USA) with 1.5%
normal horse serum and 0.2% Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA), followed by a 1-h incubation with biotinylated
horse anti-mouse IgG (1:200 dilution with 0.1% Triton X-100;
Vector Laboratories Inc., Burlingame, CA, USA). After these
incubations, the sections were processed with the avidin-biotin
procedure using Elite Vectastain reagents (Vector Laboratories
Inc., Burlingame, CA, USA). Diaminobenzidine (DAB) was used
to produce a brown cytoplasmic TH reaction product. The
sections were set on slides, dehydrated in a series of alcohols,
cleared in xylene and coverslipped.
Cell counting and imaging
The counting of labeled neurons was performed on every fourth
medulla oblongata section (40 of each 160 mm). All of the
immune-labeled neuronal perikarya in the ventrolateral medulla
(VLM; A1/C1) and nucleus tractus solitarius (NTS; A2/C2) were
counted bilaterally to quantify the extent of the anti-DbH-saporin-
induced lesion. The neurons were counted at 2006magnification
with a Nikon light microscope.
Data analysis
The changes in the RBF were expressed as a percentage of
control values (means 6 S.E.M). The renal vascular conductance
(RVC) was calculated as the ratio of the RBF by MAP and was
also expressed as a percentage of the baseline values. The changes
in the RSNA were quantified by integration (1 s) after wave
rectification and were expressed as percentages of the baseline
after subtraction of the noise level. Trigger pulses matching the
systole were used for the construction of normalized averages of
the arterial pulse and the RSNA wave. For each average, a
representative 100-s segment of the arterial pressure and the
RSNA wave was used.
The effects of treatment with anti-DbH-saporin or saporin on
the number of catecholaminergic medullary neurons are presented
as means 6 S.E.M. The number of cells counted for every section
was compared by a one-way ANOVA. Additionally, the total cell
counts for the A1, C1, A2 and C2 regions were calculated and
compared between the groups by unpaired Student’s t-tests.
Cardiovascular, RSNA and plasma sodium and blood hemoglobin
concentrations were analyzed by a two-way analysis of variance
followed by the Fisher LSD test. The differences in the baseline
levels (Table 1) between the groups were analyzed by unpaired
Student’s t-tests. A value of P,0.05 was considered to denote a
significant difference.
Author Contributions
Conceived and designed the experiments: GRP DSAC SLC. Performed
the experiments: GRP AHFO. Analyzed the data: GRP DAR. Contrib-
uted reagents/materials/analysis tools: GRP DAR DSAC SLC. Wrote the
paper: GRP DSAC SLC.
References
1. Bourque CW (2008) Central mechanisms of osmosensation and systemic
osmoregulation. Nat Rev Neurosci 9: 519–531.
2. May CN, McAllen RM, McKinley MJ (2000) Renal nerve inhibition by central
NaCl and ANG II is abolished by lesions of the lamina terminalis. Am J Physiol
Regul Integr Comp Physiol 279: R1827–R1833.
3. Pedrino GR, Rosa DA, Korim WS, Cravo SL (2008) Renal sympathoinhibition
induced by hypernatremia: involvement of A1 noradrenergic neurons. Auton
Neurosci 142: 55–63.
4. Pedrino GR, Monaco LR, Cravo SL (2009) Renal Vasodilation Induced By
Hypernatremia: Role Of Alpha-Adrenoceptors In The Median Preoptic
Nucleus. Clin Exp Pharmacol Physiol 36(12): e83–9.
5. Rauch AL, Callahan MF, Buckalew VM, Jr., Morris M (1990) Regulation of
plasma atrial natriuretic peptide by the central nervous system. Am J Physiol
Regul Integr Comp Physiol 258: R531–R535.
6. Schoorlemmer GH, Johnson AK, Thunhorst RL (2000) Effect of hyperosmotic
solutions on salt excretion and thirst in rats. Am J Physiol Regul Integr Comp
Physiol 278: R917–R923.
7. Toney GM, Chen QH, Cato MJ, Stocker SD (2003) Central osmotic regulation
of sympathetic nerve activity. Acta Physiol Scand 177: 43–55.
8. Weiss ML, Claassen DE, Hirai T, Kenney MJ (1996) Nonuniform sympathetic
nerve responses to intravenous hypertonic saline infusion. J Auton Nerv Syst 57:
109–115.
9. Pedrino GR, Nakagawa Sera CT, Cravo SL, Colombari DS (2005)
Anteroventral third ventricle lesions impair cardiovascular responses to
intravenous hypertonic saline infusion. Auton Neurosci 117: 9–16.
10. Duale H, Waki H, Howorth P, Kasparov S, Teschemacher AG, et al. (2007)
Restraining influence of A2 neurons in chronic control of arterial pressure in
spontaneously hypertensive rats. Cardiovasc Res 76: 184–193.
11. Geerling JC, Loewy AD (2007) Sodium deprivation and salt intake activate
separate neuronal subpopulations in the nucleus of the solitary tract and the
parabrachial complex. J Comp Neurol 504: 379–403.
12. Howe BM, Bruno SB, Higgs KA, Stigers RL, Cunningham JT (2004) FosB
expression in the central nervous system following isotonic volume expansion in
unanesthetized rats. Exp Neurol 187: 190–198.
13. Kasparov S, Teschemacher AG (2008) Altered central catecholaminergic
transmission and cardiovascular disease. Exp Physiol 93: 725–740.
14. Rinaman L (2011) Hindbrain noradrenergic A2 neurons: diverse roles in
autonomic, endocrine, cognitive, and behavioral functions. Am J Physiol Regul
Integr Comp Physiol 300: R222–R235.
15. Hochstenbach SL, Ciriello J (1995) Plasma Hypernatremia Induces C-Fos
Activity in Medullary Catecholaminergic Neurons. Brain Res 674: 46–54.
16. Appleyard SM, Marks D, Kobayashi K, Okano H, Low MJ, et al. (2007)
Visceral afferents directly activate catecholamine neurons in the solitary tract
nucleus. J Neurosci 27: 13292–13302.
17. Kalia M, Sullivan JM (1982) Brainstem projections of sensory and motor
components of the vagus nerve in the rat. J Comp Neurol 211: 248–265.
18. Sawchenko PE, Swanson LW (1981) Central noradrenergic pathways for the
integration of hypothalamic neuroendocrine and autonomic responses. Science
214: 685–687.
19. Ciriello J, Rosas-Arellano MP, Solano-Flores LP (1996) Direct projections to
subfornical organ from catecholaminergic neurons in the caudal nucleus of the
solitary tract. Brain Res 726: 227–232.
20. Fernandez-Galaz C, Dyer RG, Herbison AE (1994) Analysis of brainstem A1
and A2 noradrenergic inputs to the preoptic area using microdialysis in the rat.
Brain Res 636: 227–232.
21. Saphier D (1993) Electrophysiology and neuropharmacology of noradrenergic
projections to rat PVN magnocellular neurons. Am J Physiol 264: R891–R902.
22. Cravo SL, Lopes OU, Pedrino GR (2011) Involvement of catecholaminergic
medullary pathways in cardiovascular responses to acute changes in circulating
volume. Braz J Med Biol Res 44: 877–882.
23. Godino A, Giusti-Paiva A, Antunes-Rodrigues J, Vivas L (2005) Neurochemical
brain groups activated after an isotonic blood volume expansion in rats.
Neuroscience 133: 493–505.
24. Hochstenbach SL, Ciriello J (1994) Effects of plasma hypernatremia on nucleus
tractus solitarius neurons. Am J Physiol Regul Integr Comp Physiol 266:
R1916–R1921.
25. Rinaman L, Stricker EM, Hoffman GE, Verbalis JG (1997) Central c-Fos
expression in neonatal and adult rats after subcutaneous injection of hypertonic
saline. Neuroscience 79: 1165–1175.
26. Madden CJ, Ito S, Rinaman L, Wiley RG, Sved AF (1999) Lesions of the C1
catecholaminergic neurons of the ventrolateral medulla in rats using anti-
DbetaH-saporin. Am J Physiol Regul Integr Comp Physiol 277: R1063–R1075.
27. Pedrino GR, Maurino I, Almeida Colombari DS, Cravo SL (2006) Role of
catecholaminergic neurones of the caudal ventrolateral medulla in cardiovas-
cular responses induced by acute changes in circulating volume in rats. Exp
Physiol 91: 995–1005.
28. Madden CJ, Sved AF (2003) Cardiovascular regulation after destruction of the
C1 cell group of the rostral ventrolateral medulla in rats. Am J Physiol Heart
Circ Physiol 285: H2734–H2748.
29. Mozaffari MS, Roysommuti S, Shao ZH, Wyss JM (1997) Renal responses to
hypertonic saline infusion in salt-sensitive spontaneously hypertensive rats.
American Journal of the Medical Sciences 314: 370–376.
30. Shi P, Stocker SD, Toney GM (2007) Organum vasculosum laminae terminalis
contributes to increased sympathetic nerve activity induced by central
hyperosmolality. Am J Physiol Regul Integr Comp Physiol 293: R2279–R2289.
31. Antunes-Rodrigues J, Ramalho MJ, Reis LC, Menani JV, Turrin MQA, et al.
(1991) Lesions of the Hypothalamus and Pituitary Inhibit Volume-Expansion-
Induced Release of Atrial-Natriuretic-Peptide. Proc Natl Acad Sci U S A 88:
2956–2960.
A2 Noradrenergic Cells and Body Fluid Homeostasis
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37587
32. Nishida Y, Sugimoto I, Morita H, Murakami H, Hosomi H, et al. (1998)
Suppression of renal sympathetic nerve activity during portal vein infusion of
hypertonic saline. Am J Physiol Regul Integr Comp Physiol 274: R97–103.
33. Buller KM, Smith DW, Day TA (1999) Differential recruitment of hypothalamic
neuroendocrine and ventrolateral medulla catecholamine cells by non-
hypotensive and hypotensive hemorrhages. Brain Res 834: 42–54.
34. Day TA, Sibbald JR, Smith DW (1992) A1 neurons and excitatory amino acid
receptors in rat caudal medulla mediate vagal excitation of supraoptic
vasopressin cells. Brain Res 594: 244–252.
35. Smith DW, Sibbald JR, Khanna S, Day TA (1995) Rat vasopressin cell
responses to simulated hemorrhage: stimulus-dependent role for A1 noradren-
ergic neurons. Am J Physiol Regul Integr Comp Physiol 268: R1336–R1342.
36. Tanaka J, Hatakenaka S, Miyakubo H, Nomura M (2003) Noradrenaline release
in the median preoptic nucleus area caused by hemorrhage in the rat. Brain Res
Bull 60: 233–240.
37. Colombari DS, Pedrino GR, Freiria-Oliveira AH, Korim WS, Maurino IC, et
al. (2008) Lesions of medullary catecholaminergic neurons increase salt intake in
rats. Brain Res Bull 76: 572–578.
38. Day TA, Sibbald JR (1990) Involvement of the A1 cell group in baroreceptor
inhibition of neurosecretory vasopressin cells. Neurosci Lett 113: 156–162.
39. Spyer KM (1981) Neural organisation and control of the baroreceptor reflex.
Rev Physiol Biochem Pharmacol 88: 24–124.
40. Ciriello J, Caverson MM (1984) Ventrolateral medullary neurons relay
cardiovascular inputs to the paraventricular nucleus. Am J Physiol Regul Integr
Comp Physiol 246: R968–R978.
41. Cunningham ET, Jr., Sawchenko PE (1988) Anatomical specificity of
noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat
hypothalamus. J Comp Neurol 274: 60–76.
42. Tanaka J, Hayashi Y, Watai T, Fukami Y, Johkoh R, et al. (1997) A1
noradrenergic modulation of AV3V inputs to PVN neurosecretory cells.
Neuroreport 8: 3147–3150.
43. Tucker DC, Saper CB, Ruggiero DA, Reis DJ (1987) Organization of central
adrenergic pathways: I. Relationships of ventrolateral medullary projections to
the hypothalamus and spinal cord. J Comp Neurol 259: 591–603.
44. Antunes-Rodrigues J, Marubayashi U, Favaretto AL, Gutkowska J, McCann SM
(1993) Essential role of hypothalamic muscarinic and alpha-adrenergic receptors
in atrial natriuretic peptide release induced by blood volume expansion. Proc
Natl Acad Sci U S A 90: 10240–10244.
45. Bealer SL (1997) Preoptic recess alpha-adrenoceptors control cardiovascular
responses to hyperosmolality. Am J Physiol Regul Integr Comp Physiol 272:
R1283–R1289.
46. Armstrong DM, Ross CA, Pickel VM, Joh TH, Reis DJ (1982) Distribution of
dopamine-, noradrenaline-, and adrenaline-containing cell bodies in the rat
medulla oblongata: demonstrated by the immunocytochemical localization of
catecholamine biosynthetic enzymes. J Comp Neurol 212: 173–187.
A2 Noradrenergic Cells and Body Fluid Homeostasis
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37587
